PeerView Press Home Page
Before beginning, scroll to review all program information. To proceed, you must click the "Start This Activity" button.

Activity Description & Educational Objectives

In this activity, experts in hematology-oncology discuss the diagnosis and management strategies of patients with polycythemia vera. They also discuss the importance of educating patients on the nature of their disease, and they address issues arising from long-term therapy, including safety concerns.

Upon completion of this activity, participants will be able to:

  • Diagnose and perform a risk-stratification in a patient presenting with symptoms suspicious for polycythemia vera (PV)
  • Explain the disease burden of PV to a patient with a confirmed diagnosis
  • Recommend therapy for patients with low- or high-risk PV, or those progressing to post-PV myelofibrosis
  • Summarize the clinical potential of targeted therapy in higher-risk PV, including in patients unable to benefit from cytoreductive therapy
  • Communicate with patients regarding the risks and benefits of conventional and novel therapy for PV
  • Address safety, patient education, and psychosocial concerns during long-term treatment in the PV setting

Target Audience

This activity has been designed to meet the educational needs of hematologist-oncologists, oncology nurses, nurse navigators, nurse practitioners, and other clinicians involved in the management of patients with polycythemia vera.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: May 14, 2014 - May 13, 2015
Time to Complete: 45 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Ruben A. Mesa, MD, FACP
Mayo Clinic in Arizona
Mayo Clinic Cancer Center
Scottsdale, Arizona

Ruben A. Mesa, MD, FACP, has a financial interest/relationship or affiliation in the form of:

Grant/Research Support from Genentech, Inc.; Gilead; Incyte Corporation; and NS Pharma, Inc.

Interviewees

Emily A. Knight, RN, BSN, OCN
Hematology Registered Nurse Coordinator
Mayo Clinic in Arizona
Mayo Clinic Cancer Center
Scottsdale, Arizona

Emily A. Knight, RN, BSN, OCN, has a financial interest/relationship or affiliation in the form of:

Speakers Bureau participant with Celgene Corporation and Incyte Corporation.

Patti Marshock, RN, BS, OCN
Nurse Coordinator -Hematology
Mayo Clinic Arizona
Scottsdale, Arizona

Patti Marshock, RN, BS, OCN, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Carmine DeLuca
PVI, PeerView Institute for Medical Education

Carmine DeLuca has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Sponsorship, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.‚Äč

The Penn State College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G5544-14-T.

Nurses

The Institute for Advancement of Human Behavior is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This course is co-provided by IAHB and PVI, PeerView Institute for Medical Education. Maximum of 0.75 contact hour(s).

Note: Not all state nursing boards will accept programs less than 1.0 hour in length for credit. Please click here to find out the status of your state.

This CME/CNE activity is jointly provided by Penn State College of Medicine and PVI, PeerView Institute for Medical Education; the activity is also co-provided by the Institute for Advancement of Human Behavior.

This activity is supported by an educational grant from Incyte Corporation.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

 

We do not recognize you as a registered member.
Please log in by selecting your specialty below:

I have read the required activity information
Start This Activity